Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

NCT07247123 · tracked via the Priya Life Science Singapore tracker

Sponsor

National University Hospital, Singapore

Phase

Not applicable

Started

2026-06-15

Last updated

2026-09-24

Condition(s) studied

Skin CancerSkin Cancer PreventionBenign Skin Growth

Investigational drug(s) / intervention(s)

Skin Cancer Self-Detection Educational Program with gain-framingSkin Cancer Self-Detection Educational Program with loss-framingWait-list Control

Skin Cancer Self-Detection Educational Program with gain-framing: This educational website will feature gain-framing messages, emphasizing the benefits of adopting a behavior, utilising positive language and analogies. The interventional domains are (1) Education on skin cancer risk factors and epidemiology, (2) UV Protection Advice, (3) Skin Self-Examination Techniques and (4) Differentiating benign vs malignant skin conditions.

Skin Cancer Self-Detection Educational Program with loss-framing: This educational website will feature loss-framing messages, highlight the consequences of failing to adopt a behavior, utilising negative language and analogies. The interventional domains are (1) Education on skin cancer risk factors and epidemiology, (2) UV Protection Advice, (3) Skin Self-Examination Techniques and (4) Differentiating benign vs malignant skin conditions.

Wait-list Control: Participants in the control group will gain access to the intervention websites after the 4-month questionnaire is completed.

Study summary

Skin cancer is a significant public health concern, even in an Asian society like Singapore where it ranks among the top 10 cancers. This RCT tests the effectiveness of a skin cancer educational intervention to improve skin cancer outcomes among skin-of-color individuals, including the effects of gain versus loss framing.

Eligibility

Sex

ALL

Min age

16 Years

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: * Individuals aged 16 and above * Able to read and converse in English * Able to provide informed consent * Having the ability to use and interact with a web server or application. Exclusion Criteria: \- Individuals who have cognitive impairment or decline to participate. There will be no exclusion criteria based on a previous history of skin cancer.

Primary outcome measure(s)

Change in competency scores — Baseline, immediately post-intervention (for intervention arms), 4 months post-intervention
Scores measured as percentage of correct questions answered. Range from 0% to 100% with higher score indicating higher ability to differentiate benign from malignant skin lesions. Change in scores will be calculated and compared between 1. Both intervention arms with the control group at 4 months, and 2. Between gain framed and loss framed intervention arms at 4 months

Trial sites (1)

Facility	City	Region	Status
National University Hospital	Singapore	Singapore	Recruiting

More National University Hospital, Singapore trials in Singapore

Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping Starting soon

Mepitel Film Breast Recruiting

Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease Starting soon

Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients Active, not recruiting

Transcutaneous Spinal Cord Stimulation With Robotic Gait Training in Chronic SCI Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07247123 on ClinicalTrials.gov ↗ ← All trials in Singapore